REFUSAL OF TREATMENT BY RELATIVE side effect
What is REFUSAL OF TREATMENT BY RELATIVE ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
REFUSAL OF TREATMENT BY RELATIVE and Recently Reported Side Effects
REFUSAL OF TREATMENT BY RELATIVE and 15 most Active Side Effect polls
REFUSAL OF TREATMENT BY RELATIVE and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with REFUSAL OF TREATMENT BY RELATIVE
CAMPTOSAR CLARAVIS GLEEVEC METHOTREXATE MONTELUKAST NEOPROFEN PRIMAXIN REVLIMID TACROLIMUS TEMODAR WARFARINTacrolimus Side Effects Report #5487493-6
Physician from JAPAN reported TACROLIMUS problem on Sept 28, 2007. Male patient, 74 years of age, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: refusal of treatment by relative, renal impairment, shock, . TACROLIMUS dosage: 1.5 MG, /D, ORAL. During the same period patient was treated with BASEN, KINEDAK, AMARYL, FUROSEMIDE, SALOBEL, PREDNISONE, LOXONIN. Patient died on 02/10/2007.
Methotrexate Side Effects Report #5603375-0
METHOTREXATE problem was reported by a Physician from TURKEY on Jan 15, 2008. Male patient, child 6 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: cerebral haematoma, refusal of treatment by relative, . METHOTREXATE dosage: unknown. During the same period patient was treated with PREDNISONE, CYCLOPHOSPHAMIDE, VINCRISTINE, IFOSFAMIDE, CYTARABINE, ETOPOSIDE, DOXORUBICIN. Patient recovered.
Neoprofen Side Effects Report #5507659-6
Pharmacist from UNITED STATES reported NEOPROFEN problem on Nov 05, 2007. Female patient, weighting 3.79 lb, was diagnosed with patent ductus arteriosus and was treated with NEOPROFEN. After drug was administered, patient experienced the following problems/side effects: no therapeutic response, refusal of treatment by relative, renal failure, . NEOPROFEN dosage: 8 MG ONCE -LOADING DOSE- IV BOLUS 4MG Q24H X 2 IV BOLUS. During the same period patient was treated with AMPHOTERICIN B, SYNTHROID, NYSTATIN, LASIX, MORPHINE, PHENOBARBITAL. Patient was hospitalized. Patient died on 10/26/2007.
Revlimid Side Effects Report #5413597-X
REVLIMID problem was reported by a Physician from UNITED STATES on Aug 02, 2007. Female patient, 60 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: peripheral vascular disorder, refusal of treatment by relative, . REVLIMID dosage: 5 MG, DAILY, ORAL. During the same period patient was treated with COUMADIN. Patient was hospitalized. Patient recovered.
Montelukast Side Effects Report #5720672-9
Pharmacist from UNITED STATES reported MONTELUKAST problem on Apr 25, 2008. Male patient, 14 years of age, weighting 96.12 lb, was diagnosed with asthma and was treated with MONTELUKAST. After drug was administered, patient experienced the following problems/side effects: intentional overdose, refusal of treatment by relative, . MONTELUKAST dosage: 5 MG ONCE DAILY PO. During the same period patient was treated with IBUPROFEN. Patient was hospitalized. Patient recovered.
Temodar Side Effects Report #5575028-9
TEMODAR problem was reported by a Health Professional from UNITED STATES on Dec 21, 2007. Male patient, 63 years of age, weighting 243.4 lb, was diagnosed with glioblastoma multiforme and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: leukopenia, pancytopenia, refusal of treatment by relative, sepsis, thrombocytopenia, upper gastrointestinal haemorrhage, . TEMODAR dosage: 75 MG/M^2 PO. During the same period patient was treated with ZACTIMA, ALLOPURINOL, ATENOLOL, ATOVAQUONE, CARDURA, DECADRON, FOLIC ACID, KEPPRA. Patient was hospitalized. Patient recovered.
Claravis Side Effects Report #5575526-8
Physician from UNITED STATES reported CLARAVIS problem on Dec 13, 2007. Male patient, child 2 years of age, was diagnosed with brain neoplasm malignant, off label use and was treated with CLARAVIS. After drug was administered, patient experienced the following problems/side effects: brain neoplasm, neoplasm progression, refusal of treatment by relative, . CLARAVIS dosage: 20 MG, BID, ORAL. During the same period patient was treated with TEMODAR. Patient recovered.
Warfarin Side Effects Report #5739955-1
WARFARIN problem was reported by a Pharmacist from UNITED STATES on May 13, 2008. Male patient, 83 years of age, was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage, haemorrhoids, refusal of treatment by relative, . WARFARIN dosage: unknown. Patient recovered.
Gleevec Side Effects Report #5707231-9
Health Professional from UNITED STATES reported GLEEVEC problem on Apr 15, 2008. Male patient, weighting 185.2 lb, was diagnosed with glioblastoma multiforme and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased, pain, refusal of treatment by relative, . GLEEVEC dosage: 900MG PO QD. During the same period patient was treated with LISINOPRIL, HYDROCHLOROTHIAZIDE, DEPAKOTE, HYDROXYUREA, ZANTAC, PHENOBARBITAL, SINGULAIR. Patient was hospitalized. Patient recovered.
Primaxin Side Effects Report #5363704-2
PRIMAXIN problem was reported by a Pharmacist from UNITED STATES on June 18, 2007. Male patient, 49 years of age, weighting 132.0 lb, was treated with PRIMAXIN. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, dyspnoea, refusal of treatment by relative, vision blurred, . PRIMAXIN dosage: 500 MG Q12H IV. Patient died on 06/03/2007.
Camptosar Side Effects Report #5333452-3
Consumer or non-health professional from UNITED STATES reported CAMPTOSAR problem on May 22, 2007. Male patient, weighting 47.18 lb, was treated with CAMPTOSAR. After drug was administered, patient experienced the following problems/side effects: disease progression, malignant pleural effusion, refusal of treatment by relative, respiratory distress, . CAMPTOSAR dosage: 64 MG. During the same period patient was treated with VINCRISTINE SULPHATE. Patient was hospitalized. Patient died on 01/04/2005.